ThinkSono Develop Powerful AI Tool To Diagnose Deep Vein Thrombosis

ThinkSono Develop Powerful AI Tool To Diagnose Deep Vein Thrombosis

Deep vein thrombosis (DVT) occurs when a blood clot is formed in one or more of the deep veins, usually in the leg. It’s can be a very serious condition, because the blood clots can break loose, travel through the blood stream and lodge in the lungs, leading to pulmonary embolism. Over 10 million people are affected by DVT worldwide, and it kills more than 800,000 people every year. Currently, a diagnosis require an ultrasound exam by a radiologist, limiting it to an expensive and long-winded hospital setting.

The London-based startup ThinkSono is determined to improve DVT diagnosis. They have developed the world’s first software to diagnose DVT, called AutoDVT, allowing any healthcare professional to diagnose DVT at the point of care using portable ultrasound scanners. The app instructs the healthcare professional to place the probe on the skin where underlying vessels are expected, and acquire the ultrasound images and analyze them. The software guide the professional to apply pressure with the probe to compress the veins, enabling the software to check the vein segment for any clot existence. If a vein does not compress, DVT is suspected and AutoDVT informs the user and suggest further assessment of the patient.

Currently, 2 in 3 DVT deaths are not diagnosed due to a complex, time-consuming and costly process. It can take over 5 hours for a patient to be diagnosed, requiring multiple assessments from radiologists, globally costing over $10 billion every year in associated costs. ThinkSono has developed a powerful AI tool that can transform DVT diagnosis. The innovative technology could according to the startup reduce the number of patients who need to see a radiologist by 95%, resulting in a 30% faster and 10% cheaper diagnosis. In addition, by allowing any healthcare professionals to perform the procedure at point of care, it could significantly increase access to diagnosis. This will lead to improved care, potentially even better treatment options and efficacy, ultimately increasing patient outcomes and survival rates.

Fouad Al Noor and Sven Mischkewitz founded ThinkSono in November 2016 after meeting at the six-month Entrepreneurship First program in London. The startup is backed by a team of leading clinicians, engineers and investors from Berlin and London, and they are in 2017 part of Bayer’s Grants4Apps accelerator program along with 3 other digital health startups from around the globe.